Cargando…
Optimizing Tissue Sampling for the Diagnosis, Subtyping, and Molecular Analysis of Lung Cancer
Lung cancer has entered the era of personalized therapy with histologic subclassification and the presence of molecular biomarkers becoming increasingly important in therapeutic algorithms. At the same time, biopsy specimens are becoming increasingly smaller as diagnostic algorithms seek to establis...
Autores principales: | Ofiara, Linda Marie, Navasakulpong, Asma, Beaudoin, Stephane, Gonzalez, Anne Valerie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4170137/ https://www.ncbi.nlm.nih.gov/pubmed/25295226 http://dx.doi.org/10.3389/fonc.2014.00253 |
Ejemplares similares
-
Impact of rapid investigation clinic on timeliness of lung cancer diagnosis and treatment
por: Ezer, Nicole, et al.
Publicado: (2017) -
Bronchoscopic tissue yield for advanced molecular testing: are we getting enough?
por: Tajarernmuang, Pattraporn, et al.
Publicado: (2020) -
Yield of EBUS-TBNA for the diagnosis of sarcoidosis: impact of operator and cytopathologist experience
por: Navasakulpong, Asma, et al.
Publicado: (2016) -
Short-Term Lung Function Changes and Predictors of Progressive Systemic Sclerosis–Related Interstitial Lung Disease
por: Kaenmuang, Punchalee, et al.
Publicado: (2020) -
Clinical characteristics of anti‐MDA5 antibody‐positive interstitial lung disease
por: Kaenmuang, Punchalee, et al.
Publicado: (2020)